HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 49 filers reported holding HARPOON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $63 | -4.5% | 89 | 0.0% | 0.00% | – |
| Q1 2023 | $66 | +1.5% | 89 | 0.0% | 0.00% | – |
| Q4 2022 | $65 | – | 89 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 89 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 89 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 89 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 89 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -80.0% | 89 | -73.1% | 0.00% | – |
| Q2 2021 | $5,000 | -54.5% | 331 | -34.5% | 0.00% | – |
| Q1 2021 | $11,000 | -60.7% | 505 | -70.4% | 0.00% | – |
| Q4 2020 | $28,000 | +40.0% | 1,705 | +42.1% | 0.00% | – |
| Q3 2020 | $20,000 | +81.8% | 1,200 | +82.1% | 0.00% | – |
| Q2 2020 | $11,000 | +57.1% | 659 | +9.8% | 0.00% | – |
| Q1 2020 | $7,000 | +75.0% | 600 | +100.0% | 0.00% | – |
| Q4 2019 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $58,818,000 | 23.77% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $37,978,000 | 10.18% |
| EcoR1 Capital, LLC | 1,348,423 | $17,529,000 | 1.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 374,031 | $4,862,000 | 0.66% |
| Orbimed Advisors | 2,446,409 | $31,803,000 | 0.49% |
| Cormorant Asset Management, LP | 649,994 | $8,450,000 | 0.48% |
| Fosun International Ltd | 323,400 | $4,205,000 | 0.28% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 285,000 | $3,705,000 | 0.13% |
| Baker Brothers Advisors | 214,285 | $2,786,000 | 0.02% |
| UBS Group AG | 1,062 | $14,000 | 0.00% |